Additional information
White powder
1803079-49-3
ACI-123315
(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide
208.3-210.9°C
C27H30N8O3
514.58
Ambient
2-8°C
Linagliptin Acetamide; 8-[(3R)-3-Acetylamino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide;
Antidiabetic





![BUTOXYQUINOLINONE BREXPIPRAZOLE (25 mg) (7-[4-(7-{4-[4-(Benzo[b]thiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2-yloxy)butoxy]quinolin-2(1H)-one)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)